Technical acquisition and dosimetric assessment of iodine-125 permanent brachytherapy in localized prostate cancer: Our first series of 100 patients

International Journal of Urology

Volumn 16, Issue 1, 2009, Pages 70-74

  Tanaka, Nobumichi ^a   Asakawa, Isao ^a   Kondo, Hideaki ^a   Tanaka, Motoyoshi ^a   Fujimoto, Kiyohide ^a   Hasegawa, Masatoshi ^a   Konishi, Noboru ^a   Hirao, Yoshihiko ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Brachytherapy; Learning curve; Operation time; Postdosimetry; Prostate cancer

Indexed keywords

IODINE 125; PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CONTROLLED STUDY; DOSIMETRY; EXTERNAL BEAM RADIOTHERAPY; GLEASON SCORE; HEMATURIA; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OPERATION DURATION; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RECTUM HEMORRHAGE; TREATMENT OUTCOME; URINARY FREQUENCY; URINARY URGENCY; URINE RETENTION;

AGED; BRACHYTHERAPY; HUMANS; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RADIOMETRY;

EID: 58149196516     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02172.x     Document Type: Article

References (16)

1. Sobin LH, Wittekind CH. TNM Classification of Malignant Tumors, 6th edn. Wiley-Liss Inc, New York, 2002.
2. Nag S, Beyer D, Friedland J, Grimm P, Nath R. American brachytherapy society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int. J. Radiat. Oncol. Biol. Phys. 1999 44 : 789 99.
3. Nag S, Bice W, DeWyngaert K, Prestidge B, Stock R, Yu Y. The American brachytherapy society recommendations for permanent prostate brachytherapy postimplant dosimetric analysis. Int. J. Radiat. Oncol. Biol. Phys. 2000 46 : 221 30.
4. Stock RG, Stone NN, Tabert A, Iannuzzi C, DeWyngaert JK. A dose-response study for I-125 prostate implants. Int. J. Radiat. Oncol. Biol. Phys. 1998 41 : 101 8.
5. Ash D, Flynn A, Battermann J, de Reijke T, Lavagnini P, Blank L. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother. Oncol. 2000 57 : 315 21.
6. Stock RG, Stone NN. Importance of post-implant dosimetry in permanent prostate brachytherapy. Eur. Urol. 2002 41 : 434 9.
7. 90? Brachytherapy 2005 4 : 252 8.
8. 125iodine brachytherapy for prostate cancer. J. Urol. 2005 173 : 803 7.
9. Zelefsky MJ, Kuban DA, Levy LB et al. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int. J. Radiat. Oncol. Biol. Phys. 2007 67 : 327 33.
10. Sylvester JE, Grimm PD, Blasko JC et al. 15-year biochemical relapse free survival in clinical stage T1-T3 prostate cancer following combined external beam radiotherapy and brachytherapy; Seattle experience. Int. J. Radiat. Oncol. Biol. Phys. 2007 67 : 57 64.
11. Wallner K, Roy J, Harrison L. Dosimetry guidelines to minimize urethral and rectal morbidity following transperineal I-125 prostate brachytherapy. Int. J. Radiat. Oncol. Biol. Phys. 1995 32 : 465 71.
12. Han BH, Wallner KE. Dosimetric and radiographic correlates to prostate brachytherapy-related rectal complications. Int. J. Cancer 2001 96 : 372 8.
13. Ohashi T, Yorozu A, Toya K et al. Rectal morbidity following I-125 prostate brachytherapy in relation to dosimetry. Jpn. J. Clin. Oncol. 2007 37 : 121 6.
14. Okaneya T, Nishizawa S, Nakayama T, Kamigaito T, Hashida I, Hosaka N. Permanent prostate brachytherapy for Japanese men: Results from initial 100 patients with prostate cancer. Int. J. Urol. 2007 14 : 602 6.
15. Lee WR, deGuzman AF, Bare RL, Marshall MG, McCullough DL. Postimplant analysis of transperineal interstitial permanent prostate brachytherapy: Evidence for a learning curve in the first year at a single institution. Int. J. Radiat. Oncol. Biol. Phys. 2000 46 : 83 8.
16. Acher P, Popert R, Nichol J, Potters L, Morris S, Beaney R. Permanent prostate brachytherapy: Dosimetric results and analysis of a learning curve with a dynamic dose-feedback technique. Int. J. Radiat. Oncol. Biol. Phys. 2006 65 : 694 8.